June 27, 2011

Sanofi appoints Peter Guenter, Senior Vice President, Europe

- Once-Daily Lyxumia® Demonstrates Non-Inferior Reduction of Blood Glucose and Less Hypoglycemia versus Exenatide Twice Daily in Type 2 Diabetes Patients -
- Once-Daily Lyxumia® in Combination with Basal Insulin Improves Glycemic Control in Asian Type 2 Diabetes Patients -

 

Sanofi appoints Peter Guenter, Senior Vice President, Europe
- Once-Daily Lyxumia® Demonstrates Non-Inferior Reduction of Blood Glucose and Less Hypoglycemia versus Exenatide Twice Daily in Type 2 Diabetes Patients -
- Once-Daily Lyxumia® in Combination with Basal Insulin Improves Glycemic Control in Asian Type 2 Diabetes Patients -

Paris, France – June 27, 2011 – Sanofi (EURONEXT : SAN ; NYSE : SNY) is pleased to announce today the appointment of Peter Guenter, as Senior Vice President, Europe, effective July 15, 2011. He will report to Hanspeter Spek, President, Global Operations and will join the Management Committee.